# Harmonic Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/harmonic-discovery

- Industry: Biotechnology
- Headquarters: New York, US
- Website: http://www.harmonicdiscovery.com
- Total disclosed funding: $5.6M
- Latest round: Seed (Sep 14, 2021)
- Investors on record: 5

## About

Based in New York, US, and founded in 2021 by its CEO Rayees Rahman and co-founders Jason Lee, and Marcel Patek, Harmonic Discovery Inc. operates as a drug discovery company that builds an integrated computational and experimental platform. In September 2022, Harmonic Discovery raised USD 8 million in seed funding led by Innovation Endeavors, with participation from other new investors Fifty Years, Y Combinator, Boom Capital Management, and Caffeinated Capital. An individual investor also participated in the round.

Harmonic Discovery Inc. offers an integrated kinase drug discovery platform that leverages multiple layers of kinase biology to design kinase therapeutics. The company develops novel therapies across diseases such as cancer and autoimmune disorders by spanning multiple disciplines, including systems biology, cheminformatics, medicinal chemistry, and machine learning.

The company plans to use the seed funding to scale up its lab operations, build proprietary chemical libraries and expand its leadership team in order to enhance its drug discovery platform and pipeline.

## Funding rounds

- Seed, Sep 14, 2021, $5.6M — Innovation Endeavors, Y Combinator, Caffeinated Capital, Boom Capital Management, Fifty Years

## Investors

- Innovation Endeavors (https://capitalatlas.ai/funds/innovation-endeavors) — Seed
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed
- Caffeinated Capital (https://capitalatlas.ai/funds/caffeinated-capital) — Seed
- Boom Capital Management (https://capitalatlas.ai/funds/boom-capital-management) — Seed
- Fifty Years (https://capitalatlas.ai/funds/fifty-years) — Seed